TY - JOUR A2 - Inazu, Akihiro AU - Dodson, M. V. AU - Mir, P. S. AU - Hausman, G. J. AU - Guan, L. L. AU - Du, Min AU - Jiang, Z. AU - Fernyhough, M. E. AU - Bergen, W. G. PY - 2011 DA - 2011/07/24 TI - Obesity, Metabolic Syndrome, and Adipocytes SP - 721686 VL - 2011 AB - Obesity and metabolic syndromes are examples whereby excess energy consumption and energy flux disruptions are causative agents of increased fatness. Because other, as yet elucidated, cellular factors may be involved and because potential treatments of these metabolic problems involve systemic agents that are not adipose depot-specific in their actions, should we be thinking of adipose depot-specific (cellular) treatments for these problems? For sure, whether treating obesity or metabolic syndrome, the characteristics of all adipose depot-specific adipocytes and stromal vascular cells should be considered. The focus of this paper is to begin to align metabolic dysfunctions with specific characteristics of adipocytes. SN - 2090-3030 UR - https://doi.org/10.1155/2011/721686 DO - 10.1155/2011/721686 JF - Journal of Lipids PB - Hindawi Publishing Corporation KW - ER -